Skip to main content
SpringerLink
Log in

Atherosclerosis and Cardiovascular Diseases

Proceedings of the Sixth International Meeting on Atherosclerosis and Cardiovascular Diseases held in Bologna, Italy, October 27–29,1986

  • Conference proceedings
  • © 1987

Overview

Editors:
  1. S. Lenzi

    1. Istituto di Clinica Medica Generale e Terapia Medica, I dell’Università degli Studi di Bologna, Italy

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. G. C. Descovich

    1. Istituto di Clinica Medica Generale e Terapia Medica, I dell’Università degli Studi di Bologna, Italy

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (74 papers)

  1. Endogenous Opioids

    1. Dynorphin-related peptides in central and peripheral tissues: distribution and possible functions

      • S. Spampinato, S. Ferri
      Pages 383-387

    2. Aging brain and dementia: change in central opioids and ACTH

      • G. Nappi, E. Sinforiani, E. Martignoni, C. Pacchetti, F. Facchinetti, A. R. Genazzani
      Pages 389-394

    3. Relationship between endogenour opioids and the cardiovascular system: dynorphin measurement in the human heart: β-endorphin plasmatic levels assay during acute pulmonary oedema

      • P. Bernardi, F. Fontana, C. Ventura, S. Spampinato, M. Cavazza, L. Bastagli et al.
      Pages 395-398

  2. Bezafibrate, Atherosclerosis and Ischaemic Heart Disease

    1. Front Matter

      Pages 399-399
      Download chapter PDF

    2. Studies on DNA fragment length polymorphism of human apolipoprotein B gene

      • S. Calandra
      Pages 401-408

    3. Porphyrins, tumors and atherosclerosis

      • A. Pagnan, G. Jori, P. Pauletto, G. Scannapieco, S. Biffanti, C. Dal Palù
      Pages 409-414

    4. Influence of physical exercise on plasma lipoprotein pattern in healthy subjects

      • P. Oriente, G. di Fraia, A. Spanó, L. Postiglione, G. Casaburo, A. Pepe et al.
      Pages 415-423

    5. Long-term experience with bezafibrate in different types of hyperlipidemia

      • D. Sommariva, A. Branchi, M. Tirrito, D. Bonfiglioli, L. Bellintani, C. Ottomano et al.
      Pages 425-430

    6. Role of fibrinogen in atherosclerosis: therapeutic effects of bezafibrate in short-term treatment

      • G. Pagano, G. Niort, P. Nuccio, A. Bulgarelli
      Pages 431-437

  3. Nicotinic Acid Derivatives, Atherosclerosis and Ischaemic Heart Disease

    1. Front Matter

      Pages 439-439
      Download chapter PDF

    2. Effects of Acipimox on in vivo insulin sensitivity in obese subjects and NID diabetics

      • P. Cavallo-Perin, E. Pisu, A. Bruno, C. Baggiore, S. Marena, L. Boine et al.
      Pages 441-446

    3. The lipid-lowering effect of the acipimox: comparison with tiadenol and probucol

      • S. Bertolini, N. Elicio, S. Valice, G. Pistocchi, S. Cuzzolaro, G. Montagna et al.
      Pages 447-454

    4. A controlled trial on the hypolipidemic effect of Acipimox in type IIA and IIB hyperlipoproteinemia

      • M. A. Averna, A. Stanzial, F. Bonafanti, G. di Fede, G. Montalto, M. Muggeo et al.
      Pages 455-461

    5. Effect of Acipimox on serum lipids and apoproteins in type II hyperlipoproteinemia

      • A. Capurso, F. Resta, D. Ciancia, A. M. Mogavero, M. Lavezzari, R. Taverniti et al.
      Pages 463-467

    6. Long-term multicentre trial with acipimox in diabetic patients with hyperlipoproteinemia

      • M. Muggeo, M. Lavezzari, C. Montoro, G. Sacchetti
      Pages 469-472

  4. Acetylcarnitine and Ageing Brain Syndromes

    1. Front Matter

      Pages 473-473
      Download chapter PDF

    2. Experimental pharmacological aspects in brain aging

      • M. T. Ramacci, F. R. Patacchioli, O. Ghirardi, L. Ferraris, L. Angelucci
      Pages 475-481

    3. Acute effects of L-acetylcarnetine (LAC) on quantitative EEG (QEEG) and visual evoked potentials (VEPS) in patients affected by senile, presenile and alcoholic dementia. Comparison with L-carne tine

      • D. Gambi, M. Onofrj, M. Basciani, C. Censoni, A. Faricelli
      Pages 483-489

    4. The pharmacology of cognitive disturbances: Problems and perspectives

      • S. Giaquinto
      Pages 491-496

    5. L-Acetylcarnetine prevents the parkinsonian syndrome induced by MPTP in monkeys

      • M. Onofrj, M. F. Ghilardi, I. Bodis-Wollner
      Pages 497-504
Back to top

Keywords

Editors and Affiliations

  • Istituto di Clinica Medica Generale e Terapia Medica, I dell’Università degli Studi di Bologna, Italy

    S. Lenzi, G. C. Descovich

Bibliographic Information

  • Book Title: Atherosclerosis and Cardiovascular Diseases

  • Book Subtitle: Proceedings of the Sixth International Meeting on Atherosclerosis and Cardiovascular Diseases held in Bologna, Italy, October 27–29,1986

  • Editors: S. Lenzi, G. C. Descovich

  • DOI: https://doi.org/10.1007/978-94-009-3205-0

  • Publisher: Springer Dordrecht

  • eBook Packages: Springer Book Archive

  • Copyright Information: MTP Press Limited 1987

  • Softcover ISBN: 978-94-010-7938-9Published: 14 December 2011

  • eBook ISBN: 978-94-009-3205-0Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: XVIII, 571

  • Topics: Cardiology

Publish with us

Policies and ethics

Back to top

Search

Navigation